⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IVVD News
Invivyd, Inc. Common Stock
Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
IVVD
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
IVVD
Form 8-K
sec.gov
IVVD
Form 8-K
sec.gov
IVVD
Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA
globenewswire.com
IVVD
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
IVVD
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer
globenewswire.com
NBP
IVVD
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
globenewswire.com
IVVD
Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine
globenewswire.com
IVVD
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
IVVD